News

OPKO Licensee TESARO Announces Successful Achievement of Primary and All Secondary Endpoints in Third and Final Phase 3 Trial of Rolapitant

[Business Wire] – OPKO Health, Inc. , reported that its licensee, TESARO, Inc. , announced positive top-line results from the third and final Phase 3 trial of rolapitant, an investigational neurokinin-1 receptor antagonist in development for the preventi moreView todays social media effects on OPKView the latest stocks trending across Twitter. Click to view dashboardSee who OPKO is hiring next, […]

[audio] Cut the cable, keep your cable company

[at MarketWatch] – Wireless, the final frontier for cable operators, suddenly is being explored in a big way. Andrew O’Day reports. moreView todays social media effects on CMCSAView the latest stocks trending across Twitter. Click to view dashboardSee who Comcast is hiring next, click here to view […]

Pandora bouncing back, levels to watch

moreView todays social media effects on PView the latest stocks trending across Twitter. Click to view dashboardSee who Pandora is hiring next, click here to view […]

[$$] BSkyB Confirms Pay-TV Talks

moreView todays social media effects on NWSAView the latest stocks trending across Twitter. Click to view dashboardSee who News is hiring next, click here to view […]